Daljit Singh Aurora - Sep 12, 2024 Form 4 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Chief Strategy Officer
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for Daljit Singh Aurora
Stock symbol
NMRA
Transactions as of
Sep 12, 2024
Transactions value $
$0
Form type
4
Date filed
9/13/2024, 05:22 PM
Previous filing
Apr 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NMRA Common Stock 97.5K Sep 12, 2024 Direct
holding NMRA Common Stock 115K Sep 12, 2024 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NMRA Stock Option (Right to Buy) Gift $0 -138K -77.08% $0.00 40.9K Sep 12, 2024 Common Stock 138K $4.24 Direct F2, F3
transaction NMRA Stock Option (Right to Buy) Gift $0 +138K $0.00 138K Sep 12, 2024 Common Stock 138K $4.24 See footnote F1, F2
transaction NMRA Stock Option (Right to Buy) Gift $0 -136K -39.58% $0.00 208K Sep 12, 2024 Common Stock 136K $6.51 Direct F2, F4
transaction NMRA Stock Option (Right to Buy) Gift $0 +136K $0.00 136K Sep 12, 2024 Common Stock 136K $6.51 See footnote F1, F2
transaction NMRA Stock Option (Right to Buy) Gift $0 -29.7K -29.17% $0.00 72.2K Sep 12, 2024 Common Stock 29.7K $6.36 Direct F2, F5
transaction NMRA Stock Option (Right to Buy) Gift $0 +29.7K $0.00 29.7K Sep 12, 2024 Common Stock 29.7K $6.36 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Aurora Family Trust.
F2 Represents fully vested stock options transferred pursuant to an option transfer agreement dated September 12, 2024 between the Reporting Person and Aurora Family Trust, of which members of the Reporting Person's immediate family are the sole beneficiaries.
F3 25% of the shares subject to the option vest on the first anniversary measured from August 2, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F4 25% of the shares subject to the option vest on the first anniversary measured from February 1, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F5 25% of the shares subject to the option vest on the first anniversary measured from June 30, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.